Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

FDNA Telehealth AI Telegenetics Platform: Immediate Access to Genetic Analysis for Rare Diseases

FDNA Telehealth launches its revolutionary telegenetics platform with advanced facial screening, connecting parents and families to faster, more accurate genetic analysis from the comfort of their own home.


News provided by

FDNA Telehealth

Feb 18, 2021, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Fast, Advanced Genetic Analysis
Fast, Advanced Genetic Analysis

ORLANDO, Fla., Feb. 18, 2021 /PRNewswire-PRWeb/ -- With over 400 million people in the world currently paused in a diagnostic journey or misdiagnosed, there is a pressing need for faster and more accurate genetic analysis that reaches patients and their families regardless of their location and proximity to genetic specialists. A misdiagnosis can slow down access to the care needed to help individuals and their families live with a rare genetic syndrome or disease.

FDNA's AI platform is revolutionizing telegenetics and telemedicine with its facial screening technology. Its automated facial analysis technology may speed up diagnosis for individuals with a suspected rare disease or genetic syndrome. It is also connecting thousands of people to genetic specialists, speeding up diagnosis and treatment.

FDNA’s AI platform is revolutionizing telegenetics and telemedicine with its facial screening technology. Its automated facial analysis technology may speed up diagnosis for individuals with a suspected rare disease or genetic syndrome.

Post this

Since its founding in 2011, FDNA has helped clinicians, researchers, and genetic testing labs find answers for the hundreds of millions of patients living globally with a rare disease. FDNA's next-generation phenotyping technology is currently being used by 70% of the world's geneticists in over 130 countries. Having been used to help over 250,000 patients and their families understand more about their genomic makeup, FDNA Telehealth brings this analysis to help patients in a non-clinical setting and enable patients and their families to access the technology directly.

The FDNA Telehealth platform is easy to use. The first step is to submit the patient information into the secure system. The next step is to upload an image of a face for analysis. The third step after this is to make an online appointment with a genetic expert. The process has been designed to be as easy as possible for non-medical professionals.

FDNA Telehealth's advanced AI platform screens an image of a face for genetic syndromes markers (and unique facial features associated with specific genetic syndromes, such as widely-spaced eyes/hypertelorism) and provides a report with potential syndrome-matches for a geneticist to review. The next step is to connect with one of FDNA Telehealth's genetic counselors and geneticists from their network of over 7,500 worldwide. Telemedicine is leading the way in its drive to make healthcare and diagnostic tools, as well as specialist care and support, more accessible to more patients.

It is also crucial that the facial screening analysis offered by FDNA Telehealth is affordable, with in-network insurance coverage on its way. Ensuring that patients and their families can access the diagnostic tools necessary for a precise and confirmed diagnosis is very important and is the drive behind FDNA Telehealth's technology.

FDNA's facial analysis screening technology is currently used by over 10,000 hospitals, clinics, and labs. Hospitals and medical centers such as the Boston Children's Hospital, The Children's Hospital of Philadelphia, Children's Hospital Los Angeles, Tufts Medical Center, SickKids, CHEO, and more. With the launch of the FDNA Telehealth platform, this technology is available to parents, patients, and everyone else who needs it.

With FDNA's technology, a possibly faster diagnosis for many rare genetic syndromes is accessible to all. From syndromes such as Noonan syndrome to Angelman syndrome, Coffin-Siris syndrome, and more, a diagnosis can begin with just a single photo.

FDNA Telehealth is committed to protecting the privacy of its patients. All images are de-identified by their technology, and for the analysis, a de-identified representation of the image is used. Patient privacy is a priority, and their telehealth solution is both HIPAA and GDPR compliant.

As we learn more about the causes and related symptoms of rare genetic syndromes, of which there are currently over 7,000 named and identified, the need to provide individuals and families with a confirmed diagnosis as quickly as possible becomes pressingly important. Too many families are stuck in a diagnostic journey, the average time of which can be over five years to confirm a diagnosis, or facing a misdiagnosis. Utilizing advanced AI facial screening technology, FDNA Telehealth looks to change that and improve outcomes for many at the same time.

A possible faster and more accurate genetic analysis via telehealth can now start with a single photo from the comfort of your own home.

Media Contact

Ido Rabiner, FDNA Telehealth, +1 877-327-0735, [email protected]

SOURCE FDNA Telehealth

Related Links

https://fdna.health

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.